THNR
Amplify Weight Loss Drug & Treatment ETF Equity$24.90
-0.90%
(-0.23)
AUM $4.2M
Expense 59.00%
52w Low $20.98
62.2% of range
52w High $27.28
50d MA $24.60
200d MA $24.48
NAV
$24.70
AUM
$4.2M
Expense
59.00%
Holdings
20
Avg Volume
7K
Inception
May 21, 2024
Issuer
Amplify
Exchange
—
Domicile
US
ISIN
US0321085328
50d MA
$24.60
200d MA
$24.48
About
THNR provides access to global companies expected to economically benefit from weight loss drug development. THNR seeks investment results that generally correspond to the performance (before fees and expenses) of the VettaFi Weight Loss Drug & Treatment Index.
Sector Exposure
Healthcare
97.7%
Cash & Others
1.4%
Financial Services
0.9%